Close Menu

Microsoft

IP Roundup, Jun 21, 2011

Premium

California Institute of Technology, Canon, Krassen Dimitrov, Hitachi, Fujifilm, Receptors, Wayne State University, Affymetrix, Qimoda, Microsoft

Researchers at Virginia Tech; the University of North Carolina, Charlotte; and the J. Craig Venter Institute will have free access to the Azure cloud platform as part of a two-year agreement between the NSF and Microsoft.

Microsoft Research launched a beta release of the next version of the Microsoft Biology Foundation toolkit and a coding contest to develop applications for the software.

At a meeting of the Pistoia Alliance last week, six vendors unveiled four cloud-based proof-of-concept platforms designed to provide a service for pharma to store and mine proprietary and public gene databases.

Paired Ends: Feb 1, 2011

Premium

Julia Dan, Paul Tu, Joyce Peng

The study, which surveyed more than 2,000 people, found that the "results of a direct-to-consumer genomic risk test do not affect health-related behavior."

GeneSpring GX 11.5, Geneious Pro 5.3 Beta, NCBI Blast on Windows Azure cloud, Bio-Formats 4.2.1, MolQuest 2.3, DevNet, LabSolutions 5.3, PubDNA Finder, SciVerse Applications beta, Amazon Cluster GPU Instances

The Microsoft development team is asking the scientific community to submit research scenarios that will help the company develop new capabilities for version 2.0 of its MBF toolkit, scheduled for release next summer.

"It might not necessarily be an in vitro diagnostic that's going to hit the market," a Merck researcher said of the company's mass spec-based biomarker assays, "but it can certainly help us make decisions as we move a drug to market."

The technique could be used to diagnose diseases such as mental retardation, where copy number variation is a key characteristic, and as a screening tool to look for cancer biomarkers and assess drug effectiveness, the researchers said.

Pages

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.